EUROPE CONTRACEPTIVES MARKET 2019-2027

Lifesciences | Medical Devices & Consumables

EUROPE CONTRACEPTIVES MARKET 2019-2027

Market By Age Group, Education, Drugs & Devices And End Users | Forecast 2019-2027

Request Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

The Europe contraceptive market is expected to proliferate at a CAGR of 6.58% during the forecast years 2019-2027.

This countries studied in this region are:

O         France

O         Italy

O         Russia

O         Germany

O         the UK

O         Spain

O         rest of Europe

The growth of the European market can mainly be attributed to the rising cognizance among the general public regarding the importance of contraceptives. With the spurt in the population, it has become essential for the government to keep the birth-rate in check, and thus, various family planning programs have been introduced to control population expansion. To avoid unwanted pregnancies and to reduce the probability of contracting STIs, people have started using various modes of birth control. Due to technological enhancements, contraceptives have now become safer, affordable, reliable and more effective. In addition, contraceptives produced with newer advancements have been reported to show higher success rates. Women are no longer skeptical to adopt modern methods of contraception. The contraceptive market has thus boomed in the region.

The European contraceptive market can be organized on the basis of age groups, education, drugs & drivers and end users. Morning-after pills are the majorly used contraceptive drugs, whereas, condoms are the most commonly used contraceptive device.

It is imperative to adopt contraceptive techniques in order to avoid unintended pregnancies and thus maintain sexual well-being. However, risks associated with the use of contraceptives make people averse to using them. Certain contraceptives may lead to serious conditions such as blood clots, breast cancer and strokes. Misconceptions and lack of knowledge regarding the contraceptive usage is another factor restricting the market growth.

The top key players operating in the European contraceptive market are Teva Pharmaceutical Industries, Ltd., Merck & Co., Inc., Allergan, Inc., Pfizer, Inc., Agile Therapeutics, Pregna, Reckitt Benckiser PLC, Afaxys, Inc., Mayer Laboratories, Inc., Cooper Surgical, Inc., SMB Corporation, Bayer AG, Ocon Medical, Ltd., Okamoto Industries, Inc., Church & Dwight Co., Inc., Melbea and Apothecus Pharmaceutical Corporation.

Related Reports

ASIA PACIFIC ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET 2019-2027
Lifesciences

ASIA PACIFIC ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET 2019-2027

Market By Offerings, Technolog ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA-PACIFIC ALZHEIMER’S DISEASE THERAPEUTICS AND DIAGNOSTICS MARKET 2019-2027
Lifesciences

ASIA-PACIFIC ALZHEIMER’S DISEASE THERAPEUTICS AND DIAGNOSTICS MARKET 2019-2027

Market By Therapeutics & Diagn ..

VIEW REPORT
ASIA-PACIFIC BIOSURGERY MARKET 2019-2027
Lifesciences

ASIA-PACIFIC BIOSURGERY MARKET 2019-2027

Market By Product, Application ..

VIEW REPORT
ASIA-PACIFIC BLOOD PLASMA MARKET 2019-2027
Lifesciences

ASIA-PACIFIC BLOOD PLASMA MARKET 2019-2027

Market By Blood Type, Applicat ..

VIEW REPORT
ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2019-2027
Lifesciences

ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2019-2027

Market By Test Types, Technolo ..

VIEW REPORT
ASIA-PACIFIC CLEANROOM TECHNOLOGY MARKET 2019-2027
Lifesciences

ASIA-PACIFIC CLEANROOM TECHNOLOGY MARKET 2019-2027

Market By Component, End-user ..

VIEW REPORT
ASIA-PACIFIC CONTRACEPTIVE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC CONTRACEPTIVE MARKET 2019-2027

Market By Age Group, Education ..

VIEW REPORT

Table of Content

1.    CONTRACEPTIVE MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. PORTER’S FIVE FORCES MODEL

2.2.1.   THREAT OF NEW ENTRANTS

2.2.2.   THREAT OF SUBSTITUTE

2.2.3.   BARGAINING POWER OF BUYERS

2.2.4.   BARGAINING POWER OF SUPPLIERS

2.2.5.   THREAT OF COMPETITIVE RIVALRY

2.3. REGULATORY OUTLOOK

2.4. PESTEL OUTLOOK

2.5. MARKET ATTRACTIVENESS INDEX

2.6. MARKET PLAYER POSITIONING

2.7. KEY INSIGHTS

2.7.1.   ORAL CONTRACEPTIVE ARE THE MAJORLY USED CONTRACEPTIVE DRUGS

2.7.2.   CONDOMS ARE THE WIDELY USED CONTRACEPTIVES DEVICE

2.7.3.   AGE GROUP OF 15–24 YEARS ARE THE MAJOR REVENUE CONTRIBUTORS TO THE EUROPE CONTRACEPTIVE MARKET

2.8. MARKET DRIVERS

2.8.1.   GROWING COGNIZANCE FOR CONTRACEPTIVES

2.8.2.   INCREASING USAGE OF ORAL CONTRACEPTIVES TO EVADE UNPLANNED PREGNANCY

2.8.3.   SURGE IN THE INITIATIVES OF GOVERNMENT AND NGO

2.8.4.   GROWING AWARENESS ABOUT STD

2.9. MARKET RESTRAINTS

2.9.1.   SIDE EFFECTS RESTRICTING THE GROWTH OF CONTRACEPTIVES

2.9.2.   LIMITED ACCESS TO CONTRACEPTIVES

2.10.            MARKET OPPORTUNITIES

2.10.1.                RISING DISPOSABLE INCOME IN EMERGING ECONOMIES

2.10.2.                UNMET MEDICAL NEEDS IN THE EMERGING ECONOMIES

2.10.3.                TECHNOLOGICAL ADVANCEMENTS

2.11.            MARKET CHALLENGES

2.11.1.                LACK OF ACCEPTANCE OF SOCIETY

3.    CONTRACEPTIVE MARKET OUTLOOK - BY EDUCATION

3.1. LESS THAN HIGH SCHOOL

3.2. HIGH SCHOOL GRADUATE

3.3. COLLEGE GRADUATE

3.4. OTHER COLLEGE DEGREES

4.    CONTRACEPTIVE MARKET OUTLOOK - BY AGE GROUP

4.1. 15–24 YEARS

4.2. 25–34 YEARS

4.3. 35–44 YEARS

4.4. ABOVE 44 YEARS

5.    CONTRACEPTIVE MARKET OUTLOOK - BY END USER

5.1. HOUSEHOLDS

5.2. CLINICS

5.3. HOSPITALS

6.    CONTRACEPTIVE MARKET OUTLOOK - BY DRUGS AND DEVICES

6.1. CONTRACEPTIVES DRUGS

6.1.1.   ORAL CONTRACEPTIVE PILLS

6.1.2.   INJECTABLE CONTRACEPTIVES

6.1.3.   TOPICAL CONTRACEPTIVES

6.2. CONTRACEPTIVE DEVICES

6.2.1.   MALE CONDOMS

6.2.2.   FEMALE CONDOMS

6.2.3.   DIAPHRAGMS

6.2.4.   CONTRACEPTIVE SPONGES

6.2.5.   VAGINAL RINGS

6.2.6.   SUBDERMAL IMPLANTS

6.2.7.   INTRA-UTERINE DEVICES

6.2.7.1.      COPPER INTRA-UTERINE DEVICES

6.2.7.2.      HORMONAL INTRA-UTERINE DEVICES

7.    CONTRACEPTIVE MARKET - REGIONAL OUTLOOK

7.1. EUROPE

7.1.1.   COUNTRY ANALYSIS

7.1.1.1.      GERMANY

7.1.1.2.      FRANCE

7.1.1.3.      THE UNITED KINGDOM

7.1.1.4.      SPAIN

7.1.1.5.      ITALY

7.1.1.6.      RUSSIA

7.1.1.7.      REST OF EUROPE

8.    COMPETITIVE LANDSCAPE

8.1. COMPANY PROFILES

8.1.1.   ALLERGAN INC.

8.1.2.   BAYER AG

8.1.3.   MELBEA

8.1.4.   PREGNA

8.1.5.   PFIZER, INC.

8.1.6.   CHURCH & DWIGHT CO., INC.

8.1.7.   AFAXYS, INC.

8.1.8.   APOTHECUS PHARMACEUTICAL CORPORATION

8.1.9.   COOPER SURGICAL INC

8.1.10.                OKAMOTO INDUSTRIES, INC

8.1.11.                MAYER LABORATORIES, INC.

8.1.12.                AGILE THERAPEUTICS

8.1.13.                MERCK & CO., INC.

8.1.14.                RECKITT BENCKISER PLC

8.1.15.                SMB CORPORATION

8.1.16.                TEVA PHARMACEUTICAL INDUSTRIES LTD.

8.1.17.                OCON MEDICAL LTD

9.    METHODOLOGY & SCOPE

9.1. RESEARCH SCOPE

9.2. SOURCES OF DATA

9.3. RESEARCH METHODOLOGY

List of table

TABLE 1        EUROPE CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

TABLE 2        CONTRACEPTIVE   MARKET PLAYER POSITIONING OUTLOOK 2017

TABLE 3        EUROPE CONTRACEPTIVE MARKET BY EDUCATION 2019-2027 ($ MILLION)

TABLE 4        EUROPE CONTRACEPTIVE MARKET BY AGE GROUP 2019-2027 ($ MILLION)

TABLE 5        EUROPE CONTRACEPTIVE MARKET BY END USER 2019-2027 ($ MILLION)

TABLE 6        EUROPE CONTRACEPTIVE MARKET BY DRUGS AND DEVICES 2019-2027 ($ MILLION)

TABLE 7        EUROPE CONTRACEPTIVES DRUGS MARKET BY TYPE 2019-2027 ($ MILLION)

TABLE 8        EUROPE CONTRACEPTIVE DEVICES MARKET BY TYPE 2019-2027 ($ MILLION)

TABLE 9        EUROPE INTRA-UTERINE DEVICES MARKET BY TYPE 2019-2027 ($ MILLION)

TABLE 10      EUROPE CONTRACEPTIVE MARKET BY COUNTRY 2019-2027 ($ MILLION)

List of Figures

FIGURE 1      EUROPE CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 2      PORTER’S FIVE FORCE MODEL

FIGURE 3      EUROPE CONTRACEPTIVE MARKET BY LESS THAN HIGH SCHOOL 2019-2027 ($ MILLION)

FIGURE 4      EUROPE CONTRACEPTIVE MARKET BY HIGH SCHOOL GRADUATE 2019-2027 ($ MILLION)

FIGURE 5      EUROPE CONTRACEPTIVE MARKET BY COLLEGE GRADUATE 2019-2027 ($ MILLION)

FIGURE 6      EUROPE CONTRACEPTIVE MARKET BY OTHER COLLEGE DEGREES 2019-2027 ($ MILLION)

FIGURE 7      EUROPE CONTRACEPTIVE MARKET BY 15–24 YEARS 2019-2027 ($ MILLION)

FIGURE 8      EUROPE CONTRACEPTIVE MARKET BY 25–34 YEARS 2019-2027 ($ MILLION)

FIGURE 9      EUROPE CONTRACEPTIVE MARKET BY 35–44 YEARS 2019-2027 ($ MILLION)

FIGURE 10   EUROPE CONTRACEPTIVE MARKET BY ABOVE 44 YEARS 2019-2027 ($ MILLION)

FIGURE 11   EUROPE CONTRACEPTIVE MARKET BY HOUSEHOLDS 2019-2027 ($ MILLION)

FIGURE 12   EUROPE CONTRACEPTIVE MARKET BY CLINICS 2019-2027 ($ MILLION)

FIGURE 13   EUROPE CONTRACEPTIVE MARKET BY HOSPITALS 2019-2027 ($ MILLION)

FIGURE 14   EUROPE CONTRACEPTIVE MARKET BY CONTRACEPTIVES DRUGS 2019-2027 ($ MILLION)

FIGURE 15   EUROPE CONTRACEPTIVES DRUGS MARKET BY ORAL CONTRACEPTIVE PILLS 2019-2027 ($ MILLION)

FIGURE 16   EUROPE CONTRACEPTIVES DRUGS MARKET BY INJECTABLE CONTRACEPTIVES 2019-2027 ($ MILLION)

FIGURE 17   EUROPE CONTRACEPTIVES DRUGS MARKET BY TOPICAL CONTRACEPTIVES 2019-2027 ($ MILLION)

FIGURE 18   EUROPE CONTRACEPTIVE MARKET BY CONTRACEPTIVE DEVICES 2019-2027 ($ MILLION)

FIGURE 19   EUROPE CONTRACEPTIVE DEVICES MARKET BY MALE CONDOMS 2019-2027 ($ MILLION)

FIGURE 20   EUROPE CONTRACEPTIVE DEVICES MARKET BY FEMALE CONDOMS 2019-2027 ($ MILLION)

FIGURE 21   EUROPE CONTRACEPTIVE DEVICES MARKET BY DIAPHRAGMS 2019-2027 ($ MILLION)

FIGURE 22   EUROPE CONTRACEPTIVE DEVICES MARKET BY CONTRACEPTIVE SPONGES 2019-2027 ($ MILLION)

FIGURE 23   EUROPE CONTRACEPTIVE DEVICES MARKET BY VAGINAL RINGS 2019-2027 ($ MILLION)

FIGURE 24   EUROPE CONTRACEPTIVE DEVICES MARKET BY SUBDERMAL IMPLANTS 2019-2027 ($ MILLION)

FIGURE 25   EUROPE CONTRACEPTIVE DEVICES MARKET BY INTRA-UTERINE DEVICES 2019-2027 ($ MILLION)

FIGURE 26   EUROPE INTRA-UTERINE DEVICES MARKET BY COPPER INTRA-UTERINE DEVICES 2019-2027 ($ MILLION)

FIGURE 27   EUROPE INTRA-UTERINE DEVICES MARKET BY HORMONAL INTRA-UTERINE DEVICES 2019-2027 ($ MILLION)

FIGURE 28   GERMANY CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 29   FRANCE CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 30   THE UNITED KINGDOM CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 31   SPAIN CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 32   ITALY CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 33   RUSSIA CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 34   REST OF EUROPE CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;